Edith E. Schermer
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
Papers in
- Virology 14
- HIV Research and Treatment 14
-
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Rogier W. Sanders (6 shared papers)Kwinten Sliepen (4 shared papers)David C. Montefiori (3 shared papers)Alba Torrents de la Peña (3 shared papers)Celia C. LaBranche (3 shared papers)John P. Moore (3 shared papers)Judith A. Burger (3 shared papers)Steven W. de Taeye (2 shared papers)
- Journals
- npj Vaccines (4 papers)Journal of Virology (4 papers)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)Nature Communications (1 paper)Frontiers in Public Health (1 paper)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Edith E. Schermer
17 papers receiving 1.6k citations
Edith E. Schermer's Hit Papers
Peers
Comparison fields: 5 of 65
- Virology 385
- Infectious Diseases 943
- Immunology 80
- Structural Biology 7
- Molecular Biology 131
Countries citing papers authored by Edith E. Schermer
This map shows the geographic impact of Edith E. Schermer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith E. Schermer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith E. Schermer more than expected).
Fields of papers citing papers by Edith E. Schermer
This network shows the impact of papers produced by Edith E. Schermer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith E. Schermer. The network helps show where Edith E. Schermer may publish in the future.
Co-authors
The 25 scholars most cited alongside Edith E. Schermer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability Hit paper breakdown → | 2020 | 902 |
| 2 | 2020 | 152 | |
| 3 | 2017 | 138 | |
| 4 | 2019 | 116 | |
| 5 | 2018 | 68 | |
| 6 | 2016 | 60 | |
| 7 | 2017 | 31 | |
| 8 | 2021 | 22 | |
| 9 | 2022 | 21 | |
| 10 | 2021 | 17 | |
| 11 | 2020 | 16 | |
| 12 | 2022 | 13 | |
| 13 | 2022 | 13 | |
| 14 | 2018 | 10 | |
| 15 | 2024 | 7 | |
| 16 | 2020 | 5 | |
| 17 | 2023 | 5 | |
| 18 | 2025 | 0 |
About Edith E. Schermer
Edith E. Schermer is a scholar working on Virology, Infectious Diseases, General Health Professions, Cardiology and Cardiovascular Medicine and Genetics, having authored 18 papers that have together received 1.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (14 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Cardiovascular Health and Risk Factors (1 paper), Connective tissue disorders research (1 paper) and Health and Lifestyle Studies (1 paper). The work is most often cited by research in Virology (385 citations), Infectious Diseases (943 citations), Immunology (80 citations), Structural Biology (7 citations) and Molecular Biology (131 citations). Edith E. Schermer has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Rogier W. Sanders, Kwinten Sliepen, David C. Montefiori, Alba Torrents de la Peña, Celia C. LaBranche, John P. Moore, Judith A. Burger, Steven W. de Taeye, Per Johan Klasse and Maurice J.B. van den Hoff. Their work appears in journals such as npj Vaccines, Journal of Virology, Arteriosclerosis Thrombosis and Vascular Biology, Nature Communications and Frontiers in Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.